http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5286897-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c999fee6428152a996011d506925c2d7
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-14
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C271-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C269-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C269-08
filingDate 1992-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1994-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88db57cb77f47c1f71402e16dfe37649
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7c8fd06d24588c67642199a4a3a1bb0
publicationDate 1994-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5286897-A
titleOfInvention N-t-butyloxycarbonyl-3-cyclohexyl-L-alanine methyl ester in crystalline form
abstract N-t-butyloxycarbonyl-3-cyclohexyl-L-alanine methyl ester, previously known only as an oil, is provided in crystalline form. By addition of an organic solvent, such as methanol and/or n-hexane, to the ester in the form of an oil and cooling, crystals may be obtained. Alternatively, the ester in oily form may be seeded with a crystal produced previously. The crystalline material is of higher purity than the previously known oils, and is more useful than the oils as an intermediate in the pharmaceutical industry.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6657073-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005027198-A1
priorityDate 1990-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5010057-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4948913-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0189203-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127761177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID300728
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10588189
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID223748707
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226462942
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128643536
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9882138
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID224970664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226504048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90495
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75736
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129519306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230931319
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID736234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226454641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7018789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221489
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127818012
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397126
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407076

Total number of triples: 41.